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Aim 
Psychological distress is common following acquired 
brain injury (ABI), but there is very little clear 
evidence about what kinds of psychological therapies 
are helpful. Positive psychology – the study of 
wellbeing, positive characteristics, and personal 
growth – is the basis for a new type of treatment 
approach, known as positive psychotherapy. Positive 
psychotherapy aims to promote personal growth by 
increasing experiences of pleasure, engagement and 
meaning. We believe that there is a strong rationale 
to apply this intervention to reduce psychological 
distress after ABI. 
 
We conducted a pilot study of a brief positive 
psychotherapy intervention within a controlled trial 
context, with ABI survivors. The objective was to 
gather important data about the feasibility and 
acceptability of the intervention, which is essential to 
the planning and design of future trials in this area. 
 
Project Outline/Methodology 
Participants with emotional distress after ABI were 
assessed and then randomly assigned to receive brief 
positive psychotherapy as well as usual treatment 
from their clinical services, or to receive usual 
treatment only. Participants in the positive 
psychotherapy condition met with a researcher for 
eight weekly sessions of treatment. All participants 
were asked to complete questionnaires about their 
wellbeing at regular intervals, up to 20 weeks from 
baseline. Those who received the treatment were 
also asked to give detailed feedback about their 
experiences.  
 
Key Results 
Twenty-seven ABI survivors were assigned to 
positive psychotherapy (n=14) or usual treatment 
only (n=13). Not everyone who was offered 
treatment chose to take this up, or to attend all 
sessions. Those who did attend treatment gave 
positive feedback about how useable they found the 
workbooks and exercises, and how relevant they 
thought the treatment was.  
 
Sixty-three percent of the participants completed the 
final assessment at Week 20. Differences in scores on 
questionnaires about mood (DASS-21) and 
psychological wellbeing (AHI) between baseline and 
Week 20 allowed us to see what level of change we 
might expect to find in a future full-scale trial. This 
information indicated that we would need at least 
124 participants to join a future trial, in order to 
obtain clear evidence about the benefits of the 
positive psychotherapy intervention in reducing 
emotional distress. 
 
Conclusions 
Our positive psychotherapy treatment programme is 
feasible to deliver and acceptable to participants with 
ABI. This pilot study has provided important 
information that is essential to the planning of future 
trials of positive psychotherapy after ABI.  
 
What does this study add to the field? 
This is the first time that this novel psychological 
therapy programme has been tried with ABI 
survivors. We now know that this treatment approach 
is feasible and acceptable in this group. We also 
know the level of variation in questionnaire scores 
over time, which will help us to calculate how many 
participants we will need in a future trial.  
 
Implications for Practice or Policy 
If future trials provide evidence of treatment benefit, 
there is significant potential for this intervention to 
be incorporated within the NHS and/or social care 
and third sector services. We expect that treatment 
delivery could be undertaken by appropriately trained 
staff from a range of professional backgrounds (e.g. 
psychology, nursing, allied health professions), in 
both in-patient and community settings, to promote 
resilience, improve outcomes and prevent mood 
deterioration throughout the patient journey. 
 
Where to next? 
We will apply for funding to conduct a larger trial 
across multiple sites in the UK. 
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